ArgenTag joins PacBio to enable instrument-free single-cell kits to support long-read isoform sequencing at single-cell ...

Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript February 5, 2026 Illumina, Inc. beats earnings expectations.

(RTTNews) - Illumina Inc. (ILMN) released earnings for its fourth quarter that Increases, from the same period last year The company's bottom line came in at $334 million, or $2.16 per share. This ...

Total company revenue is projected at “$4.5 billion to $4.6 billion, representing reported growth of 4% to 6%,” with operating margins expected at 23.3% to 23.5% in 2026. EPS guidance is “$5.05 to ...

Investing.com -- Illumina Inc. (NASDAQ:ILMN) reported fourth-quarter earnings that beat analyst expectations, but shares plunged 8.7% in after-hours trading Thursday as the company’s flat annual ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Illumina Inc. (ILMN) on Thursday reported fourth-quarter net income of $334 million. On a per-share basis, the San Diego-based company said it had profit of $2.16.

According to Precedence Research, the global RNA analysis market size is expected to be worth USD 23.39 billion by 2035, increasing from USD 10.21 billion in 2026, with a strong CAGR of 9.65% from ...

In the prior quarter, Illumina delivered earnings of $1.34 per share, beating the $1.17 consensus by 14.5%, on revenue of $1.08 billion that topped estimates by nearly 1%. That performance was driven ...

Genomics company Illumina (NASDAQ:ILMN) in Q4 CY2025, with sales up 5% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.55 billion at the midpoint came in 3.1% above ...